CAS 2098487-39-7

2-(2,6-dioxopiperidin-3-yl)-4-(prop-2-yn-1-yloxy)isoindoline-1,3-dione

CAS : 2098487-39-7

Formule : C₁₆H₁₂N₂O₅

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 312.2769

Ref: IN-DA01LQGQ

Thalidomide-propargyl

CAS : 2098487-39-7

Thalidomide-propargyl

Degré de pureté : ≥95%

Masse moléculaire : 312.28g/mol

Ref: 54-BUP10693

Thalidomide-propargyl

CAS : 2098487-39-7

Thalidomide-propargyl, a Cereblon ligand, links proteins in PROTAC formation.

Formule : C₁₆H₁₂N₂O₅

Degré de pureté : 95.14%

Couleur et forme : Solid

Masse moléculaire : 312.28

Ref: TM-T18831

Thalidomide-propargyl

CAS : 2098487-39-7

Degré de pureté : 98%

Masse moléculaire : 312.281

Ref: 10-F986397

Thalidomide, propargyl

CAS : 2098487-39-7

Thalidomide, propargyl is a derivative of the drug thalidomide, which is a synthetic immunomodulatory compound originally developed for its sedative and antiemetic properties. This molecule is sourced from chemical modifications of thalidomide, incorporating a propargyl group to enhance its biological activity profile. Its mode of action involves the modulation of immune responses, inhibition of angiogenesis, and possibly the epigenetic regulation of target genes. Thalidomide, propargyl exhibits potential applications in cancer therapy, owing to its ability to impact tumor microenvironments, specifically by inhibiting the formation of new blood vessels that are essential for tumor growth and survival. It serves as a significant focus in medicinal chemistry for the development of novel therapeutic agents aimed at combating malignancies and providing insights into the mechanisms of action of thalidomide analogs.

Formule : C₁₆H₁₂N₂O₅

Degré de pureté : Min. 95%

Masse moléculaire : 312.28 g/mol

Ref: 3D-YID48739